Griffith research has been funded nearly $900,000 by the National Breast Cancer Foundation (NBCF) of Australia following discovery of a surprising new strategy for the treatment of one of the most common types of breast cancer.
Patients with drug resistant forms of breast cancer and some forms of pancreatic cancer may have new hope, thanks to a new drug first developed at Griffith and now being trialled in the Czech Republic.
There is new hope in the fight against resistant forms of breast cancer as Griffith HealthInstitute (GHI) research aims to...
